Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Viemed Healthcare (VMD) EPS (Basic) (2018 - 2026)

Viemed Healthcare filings provide 8 years of EPS (Basic) readings, the most recent being $0.14 for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 27.27% to $0.14 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.38, a 31.03% increase, with the full-year FY2025 number at $0.38, up 31.03% from a year prior.
  • EPS (Basic) hit $0.14 in Q4 2025 for Viemed Healthcare, up from $0.09 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.14 in Q4 2025 to a low of $0.02 in Q2 2022.
  • Median EPS (Basic) over the past 5 years was $0.06 (2022), compared with a mean of $0.07.
  • Biggest five-year swings in EPS (Basic): crashed 92.0% in 2021 and later skyrocketed 200.0% in 2023.
  • Viemed Healthcare's EPS (Basic) stood at $0.1 in 2021, then plummeted by 40.0% to $0.06 in 2022, then surged by 50.0% to $0.09 in 2023, then grew by 22.22% to $0.11 in 2024, then increased by 27.27% to $0.14 in 2025.
  • The last three reported values for EPS (Basic) were $0.14 (Q4 2025), $0.09 (Q3 2025), and $0.08 (Q2 2025) per Business Quant data.